Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

19.45
Delayed Data
As of Jun 23
 +0.80 / +4.29%
Today’s Change
13.60
Today|||52-Week Range
33.00
+3.46%
Year-to-Date

Today’s Trading

Previous close18.65
Today’s open18.60
Day’s range18.55 - 19.60
Volume1,321,354
Average volume (3 months)1,115,393
Market cap$907.5M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-404.00%
Earnings growth (this year)+693.14%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+5.47%
P/E ratioNM
Price/Sales1.64
Price/Book1.34

Competitors

 Today’s
change
Today’s
% change
BHVNBiohaven Pharmaceuti...-0.13-0.51%
AKAOAchaogen Inc-0.14-0.62%
ZIOPZIOPHARM Oncology In...+0.16+2.64%
CLLSCellectis SA+1.57+6.78%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.49
Annual revenue (last year)$519.6M
Annual profit (last year)-$34.6M
Net profit margin-6.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Financial &
Accounting Officer
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts